Crocs, Inc. (NASDAQ: CROX) was recently honored with the Executive Director’s Award from the American Podiatric Medical Association (APMA). The award recognizes CrocsRX™, a leader in medical shoe sales, as making a significant contribution to the advancement of podiatric medicine in 2007. The award will be presented at the APMA’s Annual House of Delegates Meeting in Washington, DC on April 7, 2008.

“The APMA is the leading voice in podiatric medical care, so it is a huge honor to receive their highest award,” said Eddie Scott, Director of CrocsRX™. “We look forward to continuing to work with APMA to offer ergonomic footwear and bringing those solutions to market for consumers.”

“The APMA is committed to improving the quality of life for individuals suffering from a variety of health-related ailments through podiatric solutions,” said Dr. Glenn Gastwirth, Executive Director of the APMA. “We are pleased to recognize CrocsRX™ for advancing footwear alternatives for these patients while offering fashionable designs that protect while relieving pain.”

A specialty footwear line designed for people with specific medical and therapeutic, podiatric conditions, the entire CrocsRX™ product line has received the APMA Seal of Acceptance based on a myriad of podiatric standards. Included in the CrocsRX™ line are three distinctive styles – the Relief (MSRP: $39.99), Cloud (MSRP: $39.99) and Silver Cloud (MSRP: $49.99). All three styles combine specialized features to reduce foot discomfort, including Crocs’ proprietary Croslite™ material which conforms to the foot to create a truly customized fit.

To learn more about CrocsRX™ footwear, or join the more than 3,000 doctors that either recommend shoes from the CrocsRX™ line to their patients or distribute CrocsRX™ models directly through their offices, visit www.crocsrx.com.

About Crocs, Inc:

Crocs, Inc. is a rapidly growing designer, manufacturer and retailer of footwear for men, women and children under the Crocs™ brand.

All Crocs™ brand shoes feature Crocs’ proprietary closed-cell resin, Croslite™, which represents a substantial innovation in footwear. The Croslite™ material enables us to produce soft, comfortable, lightweight, superior-gripping, non-marking and odor-resistant shoes. These unique elements make Crocs™ footwear ideal for casual wear, as well as for professional and recreational uses such as boating, hiking, hospitality and gardening. The versatile use of the material has enabled Crocs to successfully market our products to a broad range of consumers.

Crocs™ shoes are sold in more than 90 countries and come in a wide array of colors and styles. Please visit www.crocs.com for additional information.

About the American Podiatric Medical Association:

Founded in 1912, the American Podiatric Medical Association represents the nation’s premier foot and ankle physicians. The Association has component societies in 53 locations in the U.S. and its territories and a membership of close to 11,500 doctors of podiatric medicine. For free foot health information, contact APMA at 1-800-FOOTCARE (1-800-366-8227) or visit www.apma.org on the Web.